Abstract #2013: Discovery of SGI-1776, a potent and selective Pim-1 kinase inhibitor

Xiaohui Liu(Hebei Medical University), Hariprasad Vankayalapati(University of Utah), Marcy Lloyd, Steven L. Warner(SuperGen (United States)), Cory L. Grand(SuperGen (United States)), Jeremy Lamb(SuperGen (United States)), Eric Gourley(SuperGen (United States)), Bradley Wolfe, David J. Bearss(Unknown)

Cancer Research

May 1, 2009

Cited by 0

Related Papers

NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers

|Cancer Cell|2013|302

Paracrine Action of Mesenchymal Stem Cells Revealed by Single Cell Gene Profiling in Infarcted Murine Hearts

|PLoS ONE|2015|93

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

|PLoS ONE|2020|82

The mitotic serine threonine kinase, <i>Aurora-2</i>, is a potential target for drug development in human pancreatic cancer

|Molecular Cancer Therapeutics|2004|78

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel

|Clinical Cancer Research|2016|77